Zhi Yang Ph.D Overview

  • Primary Position
  • Co-Founder

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Zhi Yang Ph.D General Information

Biography

Dr. Zhi Yang is the Founder, Chairman and serves as a Managing Partner at BioVeda China Fund. He also is a Co-Founder of BioChain Institute. He serves as a Board Member at DiaCarta. He served as General Partner at BioVeda Capital. He has built portfolios of 25 companies, with 8 exits (4 IPO, 4 acquisitions). As an entrepreneur, he co-founded 7 companies, 6 of which continue to conduct business and grow. As a scientist, he was the principal inventor of more than 10 U.S. and international patents, which have been documented to have earned MNCs over $250 million. He was a senior fellow and faculty member at Rockefeller University and is now an advisor to the China Health and Medical Development Foundation, under China's Ministry of Health. He earned his Ph.D. in Molecular Biology and Biochemistry at Harvard University as a fellow of CUSBEA's first class, the first group of mainland Chinese biology scholars selected to be brought to the U.S. after China opened its doors in 1979.

Contact Information

Primary Position
Co-Founder, BioChain Institute
Education
Harvard University, Ph.D. (Doctor of Philosophy)
Harvard University, MA (Master of Arts)
Wuhan University, BS (Bachelor of Science)
Gender
Male
Email
zh
Phone
+1 (888)
Address
  • 39600 Eureka Drive
  • Newark, CA 94560
  • United States
+1 (888)

Zhi Yang Ph.D Positions (2)

Firm name Firm type Title Location Industry Since
BioChain Institute Company Co-Founder Newark, CA Diagnostic Equipment
BVCF Investor Founder, Chairman and Managing Partner Shanghai, China Venture Capital

Zhi Yang Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
BVCF Shanghai, China
DiaCarta Laboratory Services (Healthcare) Privately Held (backing) Venture Capital-Backed Pleasanton, CA

Zhi Yang Ph.D Lead Partner on Deals (11)

Zhi Yang Ph.D has been the lead partner on 11 deals. Their latest deal was with Cellenkos, a drug discovery company. The deal was made for on 04-Nov-2021.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Cellenkos 04-Nov-2021 Later Stage VC (Series A) Completed Drug Discovery Houston, TX
Oculis Holding 28-Apr-2021 Completed Drug Discovery Zug, Switzerland
DiaCarta 09-Jan-2015 Completed Laboratory Services (Healthcare) Pleasanton, CA
CARsgen Therapeutics 28-Nov-2014 Completed Biotechnology Shanghai, China
Jaguar Health 07-May-2014 Completed Pharmaceuticals San Francisco, CA
Kunshan RiboQuark Pharmaceutical Technology 07-Jan-2014 Completed Pharmaceuticals Kunshan, China
MicuRx Pharmaceuticals 22-Aug-2013 Completed Pharmaceuticals Shanghai, China
Nexchem 21-Apr-2011 Completed Drug Delivery Jinhua, China
Nexchem 16-Dec-2009 Buyout/LBO Completed Drug Delivery Jinhua, China
NOD Pharmaceuticals 30-Dec-2006 Early Stage VC (Series B) Completed Biotechnology San Diego, CA

Zhi Yang Ph.D Network (85)

Board Members (11)

Name Company Representing Location From
Folkert Kamphuis Jaguar Health Jaguar Health San Francisco, CA
Jack Kaye DiaCarta Self Pleasanton, CA
Nexchem Nexchem Jinhua, China
Jaguar Health Self San Francisco, CA
Jaguar Health Self San Francisco, CA

Portfolio Executives (71)

Name Company Role Deal date Location
Alick Sun Cellenkos Senior Vice President, Corporate & Business Development 04-Nov-2021 Houston, TX
Simrit Parmar MD Cellenkos Founder, Chief Medical Officer & President 04-Nov-2021 Houston, TX
Cellenkos Chief Operating Officer 04-Nov-2021 Houston, TX
Cellenkos Chief Operating Officer 04-Nov-2021 Houston, TX
Cellenkos Chief Technology Officer & Advisor 04-Nov-2021 Houston, TX

Fund Team Members (3)

Name Investor Fund Fund Location
Bing Zhuo BVCF BioVeda China Fund II Shanghai, China
Bing Zhuo BVCF Beijing Jinshuiquan RMB Fund Shanghai, China
BVCF Shanghai, China
BVCF Shanghai, China
BVCF Shanghai, China

Zhi Yang Ph.D Affiliated Funds (4)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
BioVeda China Fund IV BVCF Venture - General Closed 2018
BioVeda China Fund II BVCF Venture - General Closed 2007
BioVeda China Fund III BVCF Venture - General Closed 2012
Beijing Jinshuiquan RMB Fund BVCF Venture - General Closed 2016

Zhi Yang Ph.D FAQs

  • Who is Zhi Yang Ph.D?

    Dr. Zhi Yang is the Founder, Chairman and serves as a Managing Partner at BioVeda China Fund.

  • How much does Zhi Yang Ph.D typically invest?

    Zhi Yang Ph.D's median deal size is .

  • What is Zhi Yang Ph.D’s main position?

    Zhi Yang Ph.D’s primary position is Co-Founder.

  • What are the contact details for Zhi Yang Ph.D?

    Zhi Yang Ph.D’s email address is zh and his phone number is +1 (888) .

  • How many active board seats does Zhi Yang Ph.D hold?

    Zhi Yang Ph.D holds 2 board seats including BVCF and DiaCarta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »